Isatuximab Acts Through Fc-Dependent, Independent, and Direct Pathways to Kill Multiple Myeloma Cells

Chen Zhu, Zhili Song, Anlai Wang, +15

Frontiers in Immunology

<scp>ADAM</scp> 8 expression in invasive breast cancer promotes tumor dissemination and metastasis

Mathilde Romagnoli, Nora D. Mineva, Michael Polmear, +13

EMBO Molecular Medicine

PEST Motif Serine and Tyrosine Phosphorylation Controls Vascular Endothelial Growth Factor Receptor 2 Stability and Downregulation

Rosana Meyer, Srimathi Srinivasan, Amrik Singh, +3

Molecular and Cellular Biology

ImmunologyPka/p38 MapkVegfr-2 StabilityTumor BiologyAngiogenesis +21

Hypoxia-induced expression of phosducin-like 3 regulates expression of VEGFR-2 and promotes angiogenesis

Srimathi Srinivasan, Vipul C. Chitalia, Rosana Meyer, +9

Angiogenesis

<i>STAT3</i> Antisense Oligonucleotide Remodels the Suppressive Tumor Microenvironment to Enhance Immune Activation in Combination with Anti–PD-L1

Theresa A. Proia, Maneesh Singh, Richard Woessner, +19

Clinical Cancer Research

Development of a Diphtheria Toxin Based Antiporcine CD3 Recombinant Immunotoxin

Zhirui Wang, Raimon Duran‐Struuck, Rebecca L. Crepeau, +6

Bioconjugate Chemistry

Microbial ToxinAllergyAutoimmune DiseaseDiphtheria ToxinCd3+ Cells +12

Impact of Minimal Residual Disease on Progression-Free Survival Outcomes After Fixed-Duration Ibrutinib-Venetoclax Versus Chlorambucil-Obinutuzumab in the GLOW Study

Talha Munir, Carol Moreno, Carolyn Owen, +21

Journal of Clinical Oncology

Identification of PDCL3 as a Novel Chaperone Protein Involved in the Generation of Functional VEGF Receptor 2

Srimathi Srinivasan, Rosana Meyer, Ricardo Lugo, +1

Journal of Biological Chemistry

Signal TransductionSignaling PathwayReceptor Tyrosine KinaseImmunologyReceptor (Biochemistry) +5

N-Glycosylation Regulates ADAM8 Processing and Activation

Srimathi Srinivasan, Mathilde Romagnoli, Andrew Bohm, +1

Journal of Biological Chemistry

Evaluation of Preclinical Activity of Isatuximab in Patients with Acute Lymphoblastic Leukemia

Anlai Wang, Zhili Song, Gang Zheng, +8

Molecular Cancer Therapeutics